INTRODUCTION
Microbial mitogens are receiving increasing attention as possible contributors to the pathogenesis of disease and to altered immune responses. Many mycoplasmas are known to exert mitogenic effects on normal unsensitized lymphocytes from a variety of hosts [1, 2, 3] . Whereas it is the murine B-cell subpopulation which responds to M. pneumoniae, A. laidlawii, and M. neurolyticum [4, 5, 6] , both B cells and T cells respond to M. pulmonis [7] . Human T cells were also reported to be stimulated by A. laidlawii [5] and M. pneumoniae [8] . Emphasis in our laboratories has been on lymphocyte interactions with M. arthritidis. Since this organism is a potent arthritogenic agent of mice, rats, and rabbits [9] , detailed study of its lymphocyte-activating properties may provide clues as to the mechanisms of pathogenesis of the diseases induced.
In this review I will summarize current knowledge concerning the T-lymphocyteactivating component of M. arthritidis, the cellular collaborations required, and the genetic control of T-lymphocyte activation. In addition, other properties of the mitogen, including macrophage activation and ability to induce interferon, will also be described. Detailed methodology can be found in the cited references. The genetic studies are summarized in Table 1 . RESULTS
Cellular Requirements for T-Cell Activation of M. arthritidis
The first evidence that M. arthritidis might produce a T-cell activator was in our observation that viable organisms induced splenic cells to become cytotoxic for syngeneic and allogeneic fibroblast targets [10] . Furthermore, cytotoxic activity was abolished by removing T cells by treatment with anti-Thy 1 antibody and complement [11] . [15] . Furthermore, lymphocyte reactivity was shown to be dependent upon the haplotype expressed at the H2 gene complex. This conclusion was reached since congenic mouse strains, which differed from the parental strain only in the haplotype expressed at H2, always responded according to the haplotype at H2, and not the background haplotype. By using recombinant mice which express different haplotypes at different regions of the H2 complex, we identified the I-E sub-region as responsible for the genetic control of activation [15, 16] (Table 1) .
The demonstration of I-E region control for the mycoplasma mitogen appears to be unique. Although differences in the degree of responsiveness of lymphocytes from various mouse strains to the T-cell mitogens concanavalin A (Con-A) and phytohemagglutinin (PHA) have been identified, the genetic control of these differences appears to lie outside the H2 gene complex [17] .
The availability of responder and non-responder mouse strains provided an opportunity to determine whether the genetic control of lymphocyte activation was mediated at the level of the T cell or the accessory cell. We showed that purified T cells from Fl hybrids between responder (C3H) and non-responder (C57BL/6) mice were activated by MAS in the presence of accessory cells from the hybrid or the C3H mice but were not stimulated in the presence of accessory cells from C57BL/6 mice.
In contrast, T-cell responses to Con-A were supported by accessory cells from all strains of mice. Thus, the accessory cell appears to be responsible for the genetic control of lymphocyte reactivity to MAS [12] . [18] . The lesser binding may correlate with the poor phenotypic expression of Ia7 on A.TFR5 cells [19] . Most I-E regioncoded molecules consist of an a and a ,B chain. Since the 1a7 specificity when present is borne on the a chain of the molecule and since the a chain is absent from A.TFR5 mice [20] , our results imply that mitogen binding is associated with the presence of the a chain of the I-E molecule.
Thus, there appears to be complete correlation between the ability of MAS to activate lymphocytes and to bind the splenic cells (Table 1 ). An [22] . However, since peritoneal macrophages were used, the activation seen might have been mediated by lymphokine activity, generated by activation of contaminating lymphocytes. To avoid this problem, our studies were performed using the J774.1 continuous macrophage line which originated from the responder Balb/c (H2d) mouse strain.
First, we determined whether either viable M. arthritidis or MAS induced morphological changes. Whereas untreated macrophages, treated with uninoculated mycoplasma broth, exhibited a uniform smooth appearance, those exposed for 24 hours to viable M. arthritidis or MAS showed changes characteristic of those induced by BCG cell walls. Thus, the macrophages developed enhanced spreading, pseudopod-like extensions of the membrane and numerous endocytic vesicles and phagosomes [23] . Additional studies showed that macrophages treated with viable M. arthritidis or MAS and extensively washed exhibited similar changes in function to those induced with BCG cell walls, i.e., enhanced listericidal activity, acquisition of tumoricidal properties, enhanced production of acid phosphatase, and increased uptake of '4C glucosamine [23] . It remains to be determined whether the macrophage-activating component in MAS is in fact the mitogenic moiety. Mitogen purification studies now under way will eventually answer this question. The mechanisms of macrophage activation and the role of mycoplasmas to alter continuous line macrophage functions poses yet another potential pitfall for the cell biologist unaware of the presence of these contaminants.
Interferon Induction by M. arthritidis Previous studies from our laboratories indicated that mycoplasmas induced interferon in vivo in mice and in sheep and human lymphocyte cultures [24, 25, 26] . These and recent studies by other investigators [27] suggested that the interferon produced was a interferon. Alpha interferon is characteristically induced by viruses and B-cell mitogens, whereas T-cell mitogens characteristically induce immune or -y interferon. Thus our new finding that M. arthritidis produces a T-cell mitogen is paradoxical in view of the ability of this organism to induce a interferon in mice.
Preliminary studies presented at this conference [28] and now in press [Cole, Thorpe: J Immunol, 1983 ] indicate that MAS is in fact an inducer of human y interferon. We also investigated this issue using CBA mouse lymphocyte cultures with MAS. Interferon was detected after 24 hours and peaked after three to four days. The anti-viral substance was subjected to the usual criteria for acceptance as an interferon and, furthermore, was shown to be pH labile and neutralized by anti-'y interferon. antibody but not by anti-a interferon antibody. By comparing the interferon response of lymphocytes from various inbred, congenic, and recombinant mice we further demonstrated a complete correlation between the ability of MAS to induce interferon and its ability to induce lymphocyte proliferation. Thus the induction of -y interferon by MAS is also under Ir gene control (Table 1) . DISCUSSION There are many important implications which arise from these studies. First, the M. arthritidis mitogen represents a new tool to examine the mechanisms of Ir gene control of lymphocyte activation. la antigens, the proposed products of Ir genes, are considered to play a pivotal role as recognition markers for the cell collaborations necessary for generation of humoral and cellular immune responses. Our system suggests that Ia antigens might serve as receptor sites for T-lymphocyte-activating substances.
Second, since responder and non-responder mouse strains are available, we have an ideal model to examine the role of mitogen-induced lymphocyte activation in various disease processes. The chronic inflammatory disease induced by many mycoplasmas is highly suggestive of a massive stimulation of cells of the immune system. In the case of M. pulmonis, evidence has been obtained that mitogencontaining extracts can induce pneumonic lesions [29] .
Third, these studies have also shown that -y interferon induced by a microbial mitogen can also be under Ir gene control. One implication of this new finding is that this reaction may represent a potentially potent genetic control mechanism for susceptibility to infectious disease. Thus, 'y interferon, which is known to act synergistically with a interferon [30] , is becoming recognized as a powerful modulator of immune response and host defenses; M. arthritidis and some bacteria do in fact induce both a and 'y interferons.
It remains to be determined whether the genetic control of the T-cell mitogen of M. arthritidis represents a unique system or whether other mycoplasmas or bacteria will eventually be shown to possess similarly acting mitogens. Studies by Stanbridge et al. [311 using whole M. hyorhinis organisms indicated differences in the degree of proliferation of lymphocytes from different recombinant mouse strains. Differences in the degree of proliferation of LEW and F344 rat lymphocytes to M. pulmonis and other mitogens have also been reported at this conference [32] . These studies should be continued and the genetic control mechanisms identified.
